We are proud to announce that a potential new therapeutic antibody for the treatment of COVID-19 has been identified. The candidate antibody was...
Technophage’s plans for the next few years have been revealed in a brand new article in Portuguese Weekly Journal “Expresso”. The biopharma is...
During the development of TP-102 a lot of journals published pieces describing this great Technophage's milestone. This year, Jornal Expresso,...
Invest in our products
Learn more about GMP manufacturing
Who we are, What we do
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology